Kirsten Vrenken, PhD candidate in the group of Frank van Leeuwen, theme Cancer development and immune defense, has received the Tom Voûte Young Investigator Award 2018. This price is awarded each year by Kika (kinderen kankervrij) for excellent research in the area of pediatric oncology.Kirsten presented her research about the role of EMT transcription factor Snail2 in neuroblastoma.
Although Kirsten recently switched to the Van Leeuwen group at the Princess Máxima Center in Utrecht to complete her research, she has done most of the work for her research at the Radboudumc, on the basis of a RIMLS personal grant she aquired in 2014.
Tom Voûte Young Investigator Award 2018: link
Related news items
Radboud Bioinformatics Xmas event 16 December21 October 2019
The CMBI is organizing the event of the year for all bioinformaticians throughout Radboud University and Radboudumc to give you the opportunity to bring forward the biggest challenges in your research to expert bioinformaticians and pave the way for real solutions.read more
Merel Ritskes-Hoitinga has been appointed honorary Skou professor at Aarhus University17 October 2019
Merel Ritskes-Hoitinga has been appointed honorary Skou Professor at the Dept. of Clinical Medicine, at Aarhus University. The aim is to introduce new perspectives to teaching, strengthen relations with leading research units abroad and establish joint research projects and funding applications.read more
A personal touch of Maroeska te Loo15 October 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Maroeska te Loo.read more
KWF Roadshow 11 November 201910 October 2019
In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field.read more